Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a799d17d5f808bee28dc9a15345a54f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-453 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 |
filingDate |
2016-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9334d6d396c199f51b2a83b5b0ae25b5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6b3eb3561524efa2868aa46dba62783 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_591b4ff806c6ac50610adbeabf12ce05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5244e29272f2f8a2282f04626a146569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c53a22ecc9091c8db984a30e3bc9926 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8064977f49233020fe5a1baf93825aac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23cf8cbf977c05beb154a262e900b29f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0431cdd91a5303258e94fad13aee26cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ca9130350f8d4f190ec54132448a490 |
publicationDate |
2018-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2016217461-B2 |
titleOfInvention |
Amide compounds as 5-HT4 receptor agonists |
abstract |
The present invention relates to compounds of formula (I), including their stereoisomers and pharmaceutically acceptable salts. This invention also relates to methods of making such compounds and pharmaceutical compositions comprising such compounds. The compounds of this invention are useful in the treatment of various disorders that are related to 5-hydroxytryptamine 4 (5-HT |
priorityDate |
2015-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |